Handelsavisen
prelaunch
Companies Healthcare M7T.AX
M7
M7T.AX ASX Advanced Medical Equipment & Technology

Mach7 Technologies Ltd

A$0,31
Open in Charts → Attach watcher ⌖
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
72,9M AUD
P/E
EV / Rev
Div yield
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Mach7 Technologies Ltd provides healthcare equipment and technology solutions, primarily serving the healthcare services and equipment sector.

Business. Mach7 Technologies Ltd (M7T.AX) is an Australian healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Headquartered in Australia, the company is primarily listed on the Australian Securities Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target0,62

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
0,62
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning M7T.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to M7T.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Mach7 Technologies Ltd (M7T.AX) is an Australian healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Headquartered in Australia, the company is primarily listed on the Australian Securities Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million, with a current market price of AUD 0.305 per share. The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

    Profitability and returns data are not available for Mach7 Technologies Ltd, as the valuation snapshot does not include metrics such as return on invested capital (ROIC) or operating margins. Without these metrics, a direct comparison to industry peers and medians cannot be made.

    The company's segments and geographic exposure are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification.

    Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Analysts have assigned a mean price target of AUD 0.62, with a median of AUD 0.62, indicating a potential upside from the current market price.

    Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. The company is also flagged for potential liquidity risk, though the severity is not quantified. No dilution potential is indicated, as basic and diluted shares are equal.

    Recent events, such as filings or transcripts, are not disclosed in the available data, limiting insight into the company's recent strategic or operational developments.

    Key takeaways
    • Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million.
    • The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares.
    • Analysts have assigned a mean price target of AUD 0.62, suggesting potential upside from the current market price.
    • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
    • The company's profitability and returns data are not available, making it difficult to compare with industry peers.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2025-08-27
    FY 2025 · Full-year highlights

    Revenue A$34.6M, +15,4% YoY; Operating income +20,0% YoY.

    RevenueA$34.6M+15,4 % YoY
    Operating income-A$7.7M+20,0 % YoY
    Net income-A$6.2M+22,2 % YoY
    Free cash flow-A$656.6k+40,9 % YoY
    EPS
    Operating cash flowA$868.6k−74,8 % YoY
    Financials
    Income statement
    RevenueA$34.6M
    Gross profitA$32.6M
    Operating income-A$7.7M
    Net income-A$6.2M
    Margins
    Gross margin94.2%
    Operating margin-22.1%
    Net margin-17.9%
    FCF margin-1.9%
    Balance sheet
    Total assetsA$64.2M
    Total liabilitiesA$18.6M
    Total equityA$45.6M
    Cash & equivalentsA$17.3M
    Long-term debtA$1.1M
    Cash flow
    Operating cash flowA$868.6k
    CapEx-A$1.7M
    Free cash flow-A$656.6k
    SBC
    P&L flow · revenue → net income
    Revenue A$34.6MOperating costs A$42.3MNet income A$6.2M
    Highlights
    • Revenue A$34.6M, +15,4% YoY
    • Operating income +20,0% YoY
    • Net income +22,2% YoY
    • Free cash flow +40,9% YoY
    • Net margin -17.9%

    Valuation FY

    Market price
    A$0,31
    Market cap
    A$71.7M
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,02
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-12 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-0,02
    Revenueno estimateno estimate32,1M AUD
    Operating incomeno estimateno estimate-7,6M AUD
    Full-year consensus mean (period as reported by source) · consensus in AUD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy1
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price targetA$0,62 · Median A$0,62
    Low A$0,44High A$0,80
    Operating income · consensus-7,6M AUD
    EPS surprise
    −30,0 %
    reported vs consensus · miss
    Revenue surprise
    +5,0 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowA$0,44
    MeanA$0,62
    MedianA$0,62
    HighA$0,80
    SpotA$0,31
    +100.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Mach7 Technologies Ltd Market data — financials · 2026-05-28
    • Mach7 Technologies Ltd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    M7T.AXCanonical
    ASX · AUD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2025-08-27 04:08 UTCEARNINGSAnnual results — FY 2025 Revenue AUD 34.6M · Net AUD -6.2M
    2024-08-28 03:50 UTCEARNINGSAnnual results — FY 2024 Revenue AUD 30.0M · Net AUD -8.0M
    2023-08-31 03:50 UTCEARNINGSAnnual results — FY 2023 Revenue AUD 30.5M · Net AUD -1.0M
    2022-08-29 04:11 UTCEARNINGSAnnual results — FY 2022 Revenue AUD 27.1M · Net AUD -4.2M
    2021-08-23 03:49 UTCEARNINGSAnnual results — FY 2021 Revenue AUD 19.0M · Net AUD -9.4M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage